Transcription of SIGN142 Osteoporosis
{{id}} {{{paragraph}}}
Management of Osteoporosis and the prevention of fragility fracturesA national clinical guidelineFirst published March 2015 Revised June 2020 Revised January 2021 SIGN142 Key to evidence statements and recommendationsLevels of evidence1++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias1+ Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias1 Meta-analyses, systematic reviews, or RCTs with a high risk of bias2++ High-quality systematic reviews of case-control or cohort studies High-quality case-control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal2+ Well-conducted case-control or cohort studies with a low risk of confounding or bias and a moderate pr
physicians involved in care of the elderly, orthopaedic surgeons, gynaecologists, specialist nurses involved in the care of patients with osteoporosis and pharmacists. It will also be of interest to physiotherapists, occupational therapists and those involved in exercise sciences and nutritional management of people with osteoporosis.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}